Lacosamide Tablet, Film Coated
Product Images NDC 51991-348

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 51991-348). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lacosamide 01)

Chemical structure of lacosamide, the active ingredient in the human prescription drug LACOSAMIDE. The structure shows various functional groups including an acetamide, methoxy, and phenyl ring, consistent with lacosamide's molecular composition.*

FDA Label Image

Figure 1 (Lacosamide 02)

A bar chart titled 'Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose' compares seizure reduction percentages across three studies (Study 2, Study 3, Study 4). Each study presents data for placebo, Lacosamide doses (100 mg, 200 mg, 400 mg, or 600 mg) with median percent change from baseline on the y-axis. The chart illustrates higher seizure reduction percentages for Lacosamide tablets compared to placebo across doses.*

FDA Label Image

Figure 2 (Lacosamide 03)

A line graph displaying responder rates (equal to or greater improvement) versus percent of patients for Lacosamide tablets. It compares placebo with Lacosamide doses of 200 mg/day, 400 mg/day, and 600 mg/day. The y-axis shows responder rate from -100% (worsening) to 100% (improvement), and the x-axis shows percent of patients from 100 to 0. Four lines illustrate response trends across different dosages and placebo.*

FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Lacosamide 50 mg film-coated tablets label from Breckenridge Pharmaceutical, Inc. The label includes storage instructions, distributor and manufacturer information, barcode, and a note for pharmacists to dispense the accompanying medication guide. The package contains 60 tablets, indicated for oral use.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Label for Lacosamide Tablets, USP 100 mg oral film-coated tablets by Breckenridge Pharmaceutical, Inc. The label instructs that each tablet contains 100 mg lacosamide, details usual dosage storage conditions, and states the package contains 60 tablets. It also advises pharmacists to dispense with the medication guide.*

FDA Label Image

Principal Display Panel (150 mg Tablet Bottle Label)

Label for Lacosamide Tablets, USP shows the 150 mg strength in film-coated tablet form. The image includes dosage information, storage conditions (20°C to 25°C), manufacturer (MSN Laboratories Private Limited, Telangana, India), and distributor (Breckenridge Pharmaceutical, Inc., Berlin, CT, USA). The label also instructs pharmacists to dispense the accompanying medication guide and states a package size of 60 tablets.*

FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Lacosamide 200 mg film-coated tablets label showing the dosage strength prominently. The label includes storage information, distributor Breckenridge Pharmaceutical, Inc., manufacturer MSN Laboratories Private Limited (India), and a barcode. It states 'Rx Only' and contains 60 tablets per package along with a pharmacist dispensing warning.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.